MEDIFAST (MED)
(Delayed Data from NYSE)
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 4:24 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 4:24 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Kellogg (K) on Track to Optimize Portfolio With Ferrero Deal
by Zacks Equity Research
Kellogg Company (K) inks deal to divest certain cookies, pie crusts, fruit and fruit-flavored snacks, and ice cream cones businesses to Ferrero.
These Food Stocks Hit 52-Week High: Is Room for Growth Left?
by Zacks Equity Research
General Mills and TreeHouse Foods appear promising on solid growth strategies and favorable industry trends.
5 High-Yielding Stocks for an Uncertain April
by Nalak Das
The first-quarter 2019 performance does not guarantee continued success.
Can Colgate's (CL) Cost-Savings Programs Offset Margin Woes?
by Zacks Equity Research
Colgate (CL) struggles with strained margins for quite a while now. Nevertheless, the company's cost-savings program appears encouraging.
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
Medifast (MED) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medifast (MED) closed at $127.67 in the latest trading session, marking a -1.08% move from the prior day.
5 Consumer Staples Stocks for an Era of Soft Yields
by Swarup Gupta
Consumer staples are smart choices during a period of soft long-term rates, which signal a near-term economic slowdown.
Depend on DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than a simple ROE calculation? Invest in these five best bets then.
United Natural Gains 28% in 3 Months: Buyouts a Key Driver
by Zacks Equity Research
United Natural (UNFI) is on track with its SUPERVALU buyout, which contributes significantly to the top line. However, the company grapples with higher input cost.
Zacks.com featured expert Kevin Matras highlights: Kamada, Herc, Medifast, SkyWest and SP Plus
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Kamada, Herc, Medifast, SkyWest and SP Plus
General Mills Gains 6% Since Q3 Results, Hits 52-Week High
by Zacks Equity Research
General Mills (GIS) is on track with its Consumer First strategy and other cost-reduction initiatives. Also, the company benefits from buyouts, especially Blue Buffalo.
McCormick (MKC) Q1 Earnings Beat Estimates, Sales Improve Y/Y
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2019 results benefit from improved volumes and product mix.
Best 6 Bets With Sound Net Profit Margin to Lift Portfolio
by Zacks Equity Research
Let's take a look at six excellent stocks with handsome net profit margin that can build a winning portfolio.
Sprouts Farmers Down 18% in 6 Months: Will it Decline Further?
by Zacks Equity Research
Sprout Farmers (SFM) is battling elevated SG&A costs and a high debt level. Analysts are also growing bearish on the stock as apparent from downward revision in the Zacks Consensus Estimate
Zacks.com featured expert Kevin Matras highlights: Commvault Systems, Fortinet, Medifast and Evercore
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Commvault Systems, Fortinet, Medifast and Evercore
General Mills (GIS) Beats on Q3 Earnings & Sales, Updates View
by Zacks Equity Research
General Mills (GIS), which is currently focused on Consumer First strategy and cost-reduction initiatives, posts impressive third-quarter fiscal 2019 results.
Invest Carefully Despite a Dovish Fed: 5 Safe Picks
by Nalak Das
The Fed has also reduced the growth projection of U.S. GDP, while raising its previous projection for unemployment.
Grab These 4 Liquid Picks on the Top Rung for Robust Returns
by Zacks Equity Research
Here are four top-notch liquid stocks that investors can count on for superior returns.
Medifast (MED) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Medifast (MED) closed at $131.81 in the latest trading session, marking a +0.02% move from the prior day.
Conagra (CAG) Stock Rises on Q3 Earnings Beat, Sales Miss
by Zacks Equity Research
Conagra's (CAG) bottom line beats the Zacks Consensus Estimate while the top line lags the same in third-quarter fiscal 2019. Also, management revises fiscal 2019 view.
General Mills (GIS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Hain Celestial (HAIN) Down on Weak FY19 Outlook & Soft Margin
by Zacks Equity Research
Hain Celestial's (HAIN) dismal top line and high freight costs are concerns. However, Project Terra is likely to provide cushion to the stock.